位置:首页 > 蛋白库 > DSRAD_CAEEL
DSRAD_CAEEL
ID   DSRAD_CAEEL             Reviewed;         495 AA.
AC   Q22618; O76295;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-2002, sequence version 2.
DT   03-AUG-2022, entry version 150.
DE   RecName: Full=Double-stranded RNA-specific adenosine deaminase adr-2 {ECO:0000305};
DE            Short=DRADA;
DE            EC=3.5.4.37 {ECO:0000269|PubMed:12426375};
GN   Name=adr-2; ORFNames=T20H4.4;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditina; Rhabditomorpha; Rhabditoidea; Rhabditidae; Peloderinae;
OC   Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Bristol N2;
RX   PubMed=10446229; DOI=10.1093/nar/27.17.3424;
RA   Hough R.F., Lingam A.T., Bass B.L.;
RT   "Caenorhabditis elegans mRNAs that encode a protein similar to ADARs derive
RT   from an operon containing six genes.";
RL   Nucleic Acids Res. 27:3424-3432(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for investigating
RT   biology.";
RL   Science 282:2012-2018(1998).
RN   [3]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=12426375; DOI=10.1093/emboj/cdf607;
RA   Tonkin L.A., Saccomanno L., Morse D.P., Brodigan T., Krause M., Bass B.L.;
RT   "RNA editing by ADARs is important for normal behavior in Caenorhabditis
RT   elegans.";
RL   EMBO J. 21:6025-6035(2002).
RN   [4]
RP   FUNCTION, AND ROLE IN TRANSGENE SILENCING.
RX   PubMed=12419225; DOI=10.1016/s1097-2765(02)00649-4;
RA   Knight S.W., Bass B.L.;
RT   "The role of RNA editing by ADARs in RNAi.";
RL   Mol. Cell 10:809-817(2002).
RN   [5]
RP   FUNCTION.
RX   PubMed=14657490; DOI=10.1126/science.1091340;
RA   Tonkin L.A., Bass B.L.;
RT   "Mutations in RNAi rescue aberrant chemotaxis of ADAR mutants.";
RL   Science 302:1725-1725(2003).
RN   [6]
RP   INTERACTION WITH ADBP-1, SUBCELLULAR LOCATION, AND ROLE IN TRANSGENE
RP   SILENCING.
RX   PubMed=18780728; DOI=10.1534/genetics.108.093310;
RA   Ohta H., Fujiwara M., Ohshima Y., Ishihara T.;
RT   "ADBP-1 regulates an ADAR RNA-editing enzyme to antagonize RNA-
RT   interference-mediated gene silencing in Caenorhabditis elegans.";
RL   Genetics 180:785-796(2008).
RN   [7]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=18719245; DOI=10.1261/rna.1165008;
RA   Hundley H.A., Krauchuk A.A., Bass B.L.;
RT   "C. elegans and H. sapiens mRNAs with edited 3' UTRs are present on
RT   polysomes.";
RL   RNA 14:2050-2060(2008).
RN   [8]
RP   FUNCTION.
RX   PubMed=20011587; DOI=10.1371/journal.pone.0008210;
RA   Sebastiani P., Montano M., Puca A., Solovieff N., Kojima T., Wang M.C.,
RA   Melista E., Meltzer M., Fischer S.E., Andersen S., Hartley S.H.,
RA   Sedgewick A., Arai Y., Bergman A., Barzilai N., Terry D.F., Riva A.,
RA   Anselmi C.V., Malovini A., Kitamoto A., Sawabe M., Arai T., Gondo Y.,
RA   Steinberg M.H., Hirose N., Atzmon G., Ruvkun G., Baldwin C.T., Perls T.T.;
RT   "RNA editing genes associated with extreme old age in humans and with
RT   lifespan in C. elegans.";
RL   PLoS ONE 4:E8210-E8210(2009).
RN   [9]
RP   INTERACTION WITH ADR-1.
RX   PubMed=24508457; DOI=10.1016/j.celrep.2014.01.011;
RA   Washburn M.C., Kakaradov B., Sundararaman B., Wheeler E., Hoon S.,
RA   Yeo G.W., Hundley H.A.;
RT   "The dsRBP and inactive editor ADR-1 utilizes dsRNA binding to regulate A-
RT   to-I RNA editing across the C. elegans transcriptome.";
RL   Cell Rep. 6:599-607(2014).
RN   [10]
RP   FUNCTION.
RX   PubMed=25373143; DOI=10.1101/gr.176107.114;
RA   Zhao H.Q., Zhang P., Gao H., He X., Dou Y., Huang A.Y., Liu X.M., Ye A.Y.,
RA   Dong M.Q., Wei L.;
RT   "Profiling the RNA editomes of wild-type C. elegans and ADAR mutants.";
RL   Genome Res. 25:66-75(2015).
RN   [11]
RP   FUNCTION, AND MUTAGENESIS OF GLY-184.
RX   PubMed=28925356; DOI=10.7554/elife.28625;
RA   Deffit S.N., Yee B.A., Manning A.C., Rajendren S., Vadlamani P.,
RA   Wheeler E.C., Domissy A., Washburn M.C., Yeo G.W., Hundley H.A.;
RT   "The C. elegans neural editome reveals an ADAR target mRNA required for
RT   proper chemotaxis.";
RL   Elife 6:0-0(2017).
CC   -!- FUNCTION: Catalyzes the hydrolytic deamination of adenosine to inosine
CC       in double-stranded RNA (dsRNA) referred to as A-to-I RNA editing
CC       (PubMed:12426375). Acts primarily on non-coding regions of protein-
CC       coding genes including introns and untranslated regions (UTR)
CC       (PubMed:28925356, PubMed:25373143). Required for normal chemotaxis
CC       (PubMed:12426375, PubMed:14657490). Edits the 3' UTR of clec-41 which
CC       is required for normal clec-41 expression and for chemotaxis
CC       (PubMed:28925356). Plays a role in determining lifespan
CC       (PubMed:20011587, PubMed:25373143). Not required for RNA interference
CC       (PubMed:12419225). Likely to play a role in determining whether a dsRNA
CC       enters the RNAi pathway (PubMed:14657490).
CC       {ECO:0000269|PubMed:12419225, ECO:0000269|PubMed:12426375,
CC       ECO:0000269|PubMed:14657490, ECO:0000269|PubMed:20011587,
CC       ECO:0000269|PubMed:25373143, ECO:0000269|PubMed:28925356}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=adenosine in double-stranded RNA + H(+) + H2O = inosine in
CC         double-stranded RNA + NH4(+); Xref=Rhea:RHEA:10120, Rhea:RHEA-
CC         COMP:13885, Rhea:RHEA-COMP:13886, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:28938, ChEBI:CHEBI:74411,
CC         ChEBI:CHEBI:82852; EC=3.5.4.37;
CC         Evidence={ECO:0000269|PubMed:12426375};
CC   -!- SUBUNIT: Interacts with A-to-I RNA editing regulator adr-1
CC       (PubMed:24508457). Interacts with adbp-1; the interaction facilitates
CC       adr-2 nuclear localization (PubMed:18780728).
CC       {ECO:0000269|PubMed:18780728, ECO:0000269|PubMed:24508457}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:18780728}. Cytoplasm
CC       {ECO:0000269|PubMed:18780728}.
CC   -!- DEVELOPMENTAL STAGE: Highest expression observed in the embryo. Levels
CC       decrease dramatically after embryogenesis, remain relatively constant
CC       during larval stages and increase again at the onset of adulthood.
CC       {ECO:0000269|PubMed:18719245}.
CC   -!- MISCELLANEOUS: Can prevent somatic transgenes from inducing gene
CC       silencing via the RNA interference (RNAi) pathway. This may occur due
CC       to A-to-I editing of transgene-derived dsRNA, preventing transgene
CC       RNAi. {ECO:0000269|PubMed:12419225, ECO:0000269|PubMed:18780728}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF051275; AAC25097.1; -; mRNA.
DR   EMBL; FO081693; CCD73351.1; -; Genomic_DNA.
DR   PIR; T16913; T16913.
DR   PIR; T42758; T42758.
DR   RefSeq; NP_498594.1; NM_066193.4.
DR   AlphaFoldDB; Q22618; -.
DR   SMR; Q22618; -.
DR   BioGRID; 41234; 8.
DR   DIP; DIP-26710N; -.
DR   IntAct; Q22618; 1.
DR   STRING; 6239.T20H4.4; -.
DR   iPTMnet; Q22618; -.
DR   EPD; Q22618; -.
DR   PaxDb; Q22618; -.
DR   PeptideAtlas; Q22618; -.
DR   EnsemblMetazoa; T20H4.4.1; T20H4.4.1; WBGene00000080.
DR   GeneID; 176022; -.
DR   KEGG; cel:CELE_T20H4.4; -.
DR   UCSC; T20H4.4.1; c. elegans.
DR   CTD; 176022; -.
DR   WormBase; T20H4.4; CE25120; WBGene00000080; adr-2.
DR   eggNOG; KOG2777; Eukaryota.
DR   GeneTree; ENSGT00940000157243; -.
DR   HOGENOM; CLU_005382_3_1_1; -.
DR   InParanoid; Q22618; -.
DR   OMA; HAFSARW; -.
DR   OrthoDB; 947117at2759; -.
DR   PhylomeDB; Q22618; -.
DR   Reactome; R-CEL-75102; C6 deamination of adenosine.
DR   Reactome; R-CEL-77042; Formation of editosomes by ADAR proteins.
DR   PRO; PR:Q22618; -.
DR   Proteomes; UP000001940; Chromosome III.
DR   Bgee; WBGene00000080; Expressed in embryo and 4 other tissues.
DR   GO; GO:0005737; C:cytoplasm; IDA:WormBase.
DR   GO; GO:0005730; C:nucleolus; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IDA:WormBase.
DR   GO; GO:0003726; F:double-stranded RNA adenosine deaminase activity; IMP:UniProtKB.
DR   GO; GO:0003725; F:double-stranded RNA binding; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008251; F:tRNA-specific adenosine deaminase activity; IBA:GO_Central.
DR   GO; GO:0006382; P:adenosine to inosine editing; IMP:UniProtKB.
DR   GO; GO:0006935; P:chemotaxis; IEA:UniProtKB-KW.
DR   GO; GO:0008340; P:determination of adult lifespan; IMP:UniProtKB.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0050921; P:positive regulation of chemotaxis; IMP:UniProtKB.
DR   GO; GO:0006396; P:RNA processing; IBA:GO_Central.
DR   InterPro; IPR002466; A_deamin.
DR   InterPro; IPR014720; dsRBD_dom.
DR   Pfam; PF02137; A_deamin; 1.
DR   Pfam; PF00035; dsrm; 1.
DR   SMART; SM00552; ADEAMc; 1.
DR   PROSITE; PS50141; A_DEAMIN_EDITASE; 1.
DR   PROSITE; PS50137; DS_RBD; 1.
PE   1: Evidence at protein level;
KW   Chemotaxis; Cytoplasm; Hydrolase; Metal-binding; mRNA processing; Nucleus;
KW   Reference proteome; RNA-binding; Zinc.
FT   CHAIN           1..495
FT                   /note="Double-stranded RNA-specific adenosine deaminase
FT                   adr-2"
FT                   /id="PRO_0000171778"
FT   DOMAIN          36..105
FT                   /note="DRBM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00266"
FT   DOMAIN          167..492
FT                   /note="A to I editase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00240"
FT   ACT_SITE        193
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00240"
FT   BINDING         191
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00240"
FT   BINDING         244
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00240"
FT   BINDING         305
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00240"
FT   MUTAGEN         184
FT                   /note="G->R: Abolishes editing of clec-41 RNA, leads to a
FT                   threefold reduction in expression of clec-41 mRNA in neural
FT                   cells and impairs chemotaxis."
FT                   /evidence="ECO:0000269|PubMed:28925356"
SQ   SEQUENCE   495 AA;  55320 MW;  EDE9D9E06A5A8A89 CRC64;
     MSVEEGMEVE LKSEKMDLDD NIPDFVKETV ERSGKNPMSL FSELYVHMTG NTPVFDFYNR
     NQPNGSMKFI CVVILNGERI EGNVKSKKKE AKVSCSLKGL EVVLKHVSEY VVPAVKFEEK
     TTFFEMLREH TYAKFYELCK NNALIYGFEK VIASVFLKIN GNLQIIALST GNKGLRGDKI
     VNDGTALIDC HAEILARRGL LRFLYSEVLK FSTEPPNSIF TKGKNALVLK PGISFHLFIN
     TAPCGVARID KKLKPGTSDD LQNSSRLRFK IDKGMGTVLG GASEFEAPQT FDGIMMGERM
     RTMSCSDKLL RANVLGVQGA ILSHFIDPIY YSSIAVAELN NADRLRKAVY SRAATFKPPA
     PFHVQDVEIG ECQVEDTEQS TSAAARSTIS SMNWNLADGN TEVVRTSDGM VHDKDMSGAD
     ITTPSRLCKK NMAELMITIC TLTKTSVDYP ISYEELKAGS QEYAAAKKSF ITWLRQKDLG
     IWQRKPREFQ MFTIN
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024